(PharmaNewsWire.Com, January 04, 2017 ) Cardiac rhythm management (CRM) comprises any method of treatment aimed at regulating the hearts rhythm, including medication, medical devices, and occasionally surgery. There can be a number of reasons why CRM is needed, all of which generally involve malfunctions of the hearts electrical system, and are related to cardiac dyssynchrony. While medication can be effective in mild to moderate cases, patients with more severe conditions must turn to device use or surgical intervention in order to receive the therapy they require. Over the years, CRM device treatment has become less invasive, and significant advances in pacing and pulse generator technology have enabled effective long-term device therapy with limited complications.
The report identifies and analyzes the key companies shaping and driving the global CRM market. The report provides insight into the competitive CRM landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading cardiologists, with in-house analysis conducted by GlobalDatas team of industry experts.
Investigation of current and future market competition for CRM Competitor assessment including device approval analysis. Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists using CRM devices in clinical practice.
1 Table of Contents 1 Table of Contents 2 1.1 List of Tables 6 1.2 List of Figures 10
2 Introduction 11 2.1 Catalyst 11
3 Competitive Assessment 13 3.1 Overview 13 3.2 Global Market Share 13 3.2.1 Pacemaker and CRT-P Market Company Share Globally 13 3.2.2 ICD and CRT-D Market Company Share Globally 15 3.3 Regional Market Share 16 3.3.1 Pacemaker and CRT-P Market Company Share in the US 16
For More Information Kindly Contact:
ResearchMoz Mr. Nachiket Ghumare, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email: email@example.com Follow us on LinkedIn @ http://bit.ly/1TBmnVG
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: